PD-L1 expression in human cancers and its association with clinical outcomes | |
Wang, Xin; Teng, Feifei; Kong, Li; Yu, Jinming | |
刊名 | ONCOTARGETS AND THERAPY
![]() |
2016 | |
卷号 | 9页码:5023-5039 |
关键词 | PD-L1 prognostic value checkpoint blockade immunotherapy clinical outcome |
DOI | 10.2147/OTT.S105862 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4763600 |
专题 | 山东大学 |
作者单位 | 1.Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Peoples R China. 2.Shandon |
推荐引用方式 GB/T 7714 | Wang, Xin,Teng, Feifei,Kong, Li,et al. PD-L1 expression in human cancers and its association with clinical outcomes[J]. ONCOTARGETS AND THERAPY,2016,9:5023-5039. |
APA | Wang, Xin,Teng, Feifei,Kong, Li,&Yu, Jinming.(2016).PD-L1 expression in human cancers and its association with clinical outcomes.ONCOTARGETS AND THERAPY,9,5023-5039. |
MLA | Wang, Xin,et al."PD-L1 expression in human cancers and its association with clinical outcomes".ONCOTARGETS AND THERAPY 9(2016):5023-5039. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论